ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

MOUNTAIN VIEW, Calif. & NEW YORK--(BUSINESS WIRE)--DNAnexus, Inc., provider of the leading enterprise platform for precision health data, and Panomics, Inc., provider of AI-powered omics data ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

The field of exercise science is rapidly evolving through the integration of omics technologies, giving rise to promising subdisciplines such as enduromics ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...

Only one in four transplant waitlisted patients receive a life-saving organ. Xenotransplantation of pig organs into humans is a promising avenue for addressing organ shortage. Understanding the immune ...